Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Qirui Pharmaceutical is a comprehensive pharmaceutical enterprise based in Lianyungang, China, specializing in the research, development, and large-scale production of chemical APIs and finished dosage forms. The company maintains a strong focus on anti-infective agents, particularly macrolide antibiotics, alongside a portfolio of cardiovascular and gastrointestinal medications. Operating with multiple GMP-certified production lines, Jiangsu Qirui serves as a significant supplier for both the domestic Chinese market and international clients. The firm is recognized for its integration of chemical synthesis capabilities with advanced formulation technologies to produce high-quality generic medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Qirui Pharmaceutical.